• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体成像监测骨髓间充质干细胞移植治疗心肌梗死的分化及疗效

In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction.

机构信息

Department of PET Center and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China.

Department of Infection Control, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China.

出版信息

Sci Rep. 2017 Jul 24;7(1):6296. doi: 10.1038/s41598-017-06571-8.

DOI:10.1038/s41598-017-06571-8
PMID:28740146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5524783/
Abstract

Here, we used a noninvasive multimodality imaging approach to monitor differentiation of transplanted bone marrow mesenchymal stem cells (BMSCs) and recovery of cardiac function in an in vivo model of myocardial infarction (MI). We established a rat MI model by coronary artery ligation. Ninety rats were randomly assigned into four groups: sham-operated, MI model, and α-MHC-HSV1-tk-transfected or un-transfected BMSCs-treated MI model. We used F-Fluro-deoxyglucose (F-FDG) positron emission tomography (PET) to monitor recovery of cardiac function, and F-FHBG PET/CT imaging to monitor transplanted BMSCs differentiation 24 h after F-FDG imaging. The uptake of F-FDG at 3, 16, 30 and 45 days after BMSCs injection was 0.39 ± 0.03, 0.57 ± 0.05, 0.59 ± 0.04, and 0.71 ± 0.05% ID/g, respectively. Uptake of F-FHBG increased significantly in large areas in the BMSCs-treated group over time. Ex vivo experiments indicated that expression of the cardiomyocyte markers GATA-4 and cardiac troponin I markedly increased in the BMSCs-treated group. Additionally, immunohistochemistry revealed that HSV-tk-labelled BMSCs-derived cells were positive for cardiac troponin I. Multimodal imaging systems combining an α-MHC-HSV1-tk/F-FHBG reporter gene and F-FDG metabolism imaging could be used to track differentiation of transplanted BMSCs and recovery of cardiac function in MI.

摘要

在这里,我们使用一种非侵入性的多模态成像方法来监测移植骨髓间充质干细胞(BMSCs)的分化和体内心肌梗死(MI)模型中心功能的恢复。我们通过冠状动脉结扎建立了大鼠 MI 模型。90 只大鼠被随机分为四组:假手术组、MI 模型组、α-MHC-HSV1-tk 转染或未转染 BMSCs 治疗的 MI 模型组。我们使用 F-Fluro-脱氧葡萄糖(F-FDG)正电子发射断层扫描(PET)来监测心脏功能的恢复,并使用 F-FHBG PET/CT 成像来监测 F-FDG 成像后 24 小时移植的 BMSCs 分化情况。在 BMSCs 注射后 3、16、30 和 45 天,F-FDG 的摄取量分别为 0.39±0.03、0.57±0.05、0.59±0.04 和 0.71±0.05% ID/g。随着时间的推移,BMSCs 治疗组中 F-FHBG 的摄取量在大片区域内显著增加。离体实验表明,BMSCs 治疗组中心肌细胞标志物 GATA-4 和心肌肌钙蛋白 I 的表达显著增加。此外,免疫组织化学显示 HSV-tk 标记的 BMSCs 衍生细胞对心肌肌钙蛋白 I 呈阳性。结合α-MHC-HSV1-tk/F-FHBG 报告基因和 F-FDG 代谢成像的多模态成像系统可用于跟踪移植 BMSCs 的分化和 MI 中心功能的恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/76d5a65c393a/41598_2017_6571_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/3b26f1d506b3/41598_2017_6571_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/6f4167d212ec/41598_2017_6571_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/1dced674518b/41598_2017_6571_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/743072755522/41598_2017_6571_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/76d5a65c393a/41598_2017_6571_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/3b26f1d506b3/41598_2017_6571_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/6f4167d212ec/41598_2017_6571_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/1dced674518b/41598_2017_6571_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/743072755522/41598_2017_6571_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76b/5524783/76d5a65c393a/41598_2017_6571_Fig5_HTML.jpg

相似文献

1
In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction.在体成像监测骨髓间充质干细胞移植治疗心肌梗死的分化及疗效
Sci Rep. 2017 Jul 24;7(1):6296. doi: 10.1038/s41598-017-06571-8.
2
Molecular imaging to monitor repair of myocardial infarction using genetically engineered bone marrow-derived mesenchymal stem cells.利用基因工程改造的骨髓间充质干细胞进行分子成像以监测心肌梗死的修复
Curr Gene Ther. 2015;15(5):460-71. doi: 10.2174/1566523215999150421164034.
3
PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.正电子发射断层扫描(PET)监测血管内皮生长因子和骨髓间充质干细胞治疗后梗死心肌的血管生成情况。
Amino Acids. 2016 Mar;48(3):811-820. doi: 10.1007/s00726-015-2129-4. Epub 2015 Nov 23.
4
CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.CD51 区分了具有不同迁移潜能的骨髓间充质干细胞亚群:一种用于治疗小鼠急性心肌梗死的新型基于细胞的策略。
Stem Cell Res Ther. 2019 Nov 20;10(1):331. doi: 10.1186/s13287-019-1439-y.
5
Using tyrosinase as a tri-modality reporter gene to monitor transplanted stem cells in acute myocardial infarction.利用酪氨酸酶作为三模态报告基因监测急性心肌梗死中的移植干细胞。
Exp Mol Med. 2018 Apr 27;50(4):1-10. doi: 10.1038/s12276-018-0080-7.
6
Permanently Hypoxic Cell Culture Yields Rat Bone Marrow Mesenchymal Cells with Higher Therapeutic Potential in the Treatment of Chronic Myocardial Infarction.永久性缺氧细胞培养产生在慢性心肌梗死治疗中具有更高治疗潜力的大鼠骨髓间充质细胞。
Cell Physiol Biochem. 2017;44(3):1064-1077. doi: 10.1159/000485406. Epub 2017 Nov 27.
7
[Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].[粒细胞集落刺激因子与携带肝细胞生长因子基因的骨髓间充质干细胞联合治疗对大鼠心肌梗死血管生成的影响]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011 Jun;25(6):736-40.
8
Exogenous Nkx2.5- or GATA-4-transfected rabbit bone marrow mesenchymal stem cells and myocardial cell co-culture on the treatment of myocardial infarction in rabbits.外源性Nkx2.5或GATA-4转染的兔骨髓间充质干细胞与心肌细胞共培养对兔心肌梗死的治疗作用
Mol Med Rep. 2015 Aug;12(2):2607-21. doi: 10.3892/mmr.2015.3775. Epub 2015 May 12.
9
Molecular imaging of myogenic stem/progenitor cells with [F]-FHBG PET/CT system in SCID mice model of post-infarction heart.利用 [F]-FHBG PET/CT 系统对梗死心肌后 SCID 小鼠模型中的成肌干细胞/祖细胞进行分子成像。
Sci Rep. 2021 Oct 6;11(1):19825. doi: 10.1038/s41598-021-98861-5.
10
Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.负载骨髓间充质干细胞的纤维蛋白贴片在慢性心肌梗死中充当旁分泌因子的储库。
J Tissue Eng Regen Med. 2017 Dec;11(12):3417-3427. doi: 10.1002/term.2255. Epub 2017 Feb 3.

引用本文的文献

1
Tracking adipose-derived mesenchymal stromal cells in the eye: Integrating IVIS imaging and Alu PCR for enhanced detection of human cells.追踪眼部脂肪来源的间充质基质细胞:整合IVIS成像和Alu PCR以增强对人类细胞的检测。
Regen Ther. 2025 Jul 5;30:333-338. doi: 10.1016/j.reth.2025.06.018. eCollection 2025 Dec.
2
Future direction: molecular imaging-based stem cell research.未来方向:基于分子成像的干细胞研究。
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1614-1617. doi: 10.1007/s00259-025-07067-8.
3
Cardiac Mesenchymal Stem Cells Promote Fibrosis and Remodeling in Heart Failure: Role of PDGF Signaling.

本文引用的文献

1
Stem cell death and survival in heart regeneration and repair.心脏再生与修复中的干细胞死亡和存活
Apoptosis. 2016 Mar;21(3):252-68. doi: 10.1007/s10495-015-1203-4.
2
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair.人胚胎干细胞衍生的心肌细胞、心血管祖细胞和骨髓单核细胞在心脏修复中的比较。
Stem Cell Reports. 2015 Nov 10;5(5):753-762. doi: 10.1016/j.stemcr.2015.09.011.
3
Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?
心脏间充质干细胞促进心力衰竭中的纤维化和重塑:血小板衍生生长因子信号传导的作用
JACC Basic Transl Sci. 2022 Apr 20;7(5):465-483. doi: 10.1016/j.jacbts.2022.01.004. eCollection 2022 May.
4
Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances.用于1型糖尿病免疫治疗的纳米技术:有前景的创新与未来进展
Pharmaceutics. 2022 Mar 15;14(3):644. doi: 10.3390/pharmaceutics14030644.
5
Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies.间充质干细胞衍生外泌体在心血管疾病和神经退行性疾病治疗中的应用新进展
Pharmaceutics. 2022 Mar 11;14(3):618. doi: 10.3390/pharmaceutics14030618.
6
Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies.器官纤维化中干细胞治疗的前景:动物模型与人体研究
Life (Basel). 2021 Oct 11;11(10):1068. doi: 10.3390/life11101068.
7
Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light.对抗人类早衰和生理性衰老的细胞及无细胞疗法:间充质干细胞崭露头角。
J Pers Med. 2021 Oct 18;11(10):1043. doi: 10.3390/jpm11101043.
8
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.基于间充质干细胞/基质细胞的治疗:精准临床应用的机制、系统安全性和生物分布。
J Biomed Sci. 2021 Apr 14;28(1):28. doi: 10.1186/s12929-021-00725-7.
9
BMI1 in the heart: Novel functions beyond tumorigenesis.BMI1 在心脏中的作用:除了肿瘤发生之外的新功能。
EBioMedicine. 2021 Jan;63:103193. doi: 10.1016/j.ebiom.2020.103193. Epub 2021 Jan 6.
10
Functions of Mesenchymal Stem Cells in Cardiac Repair.间质干细胞在心脏修复中的作用。
Adv Exp Med Biol. 2021;1312:39-50. doi: 10.1007/5584_2020_598.
量化氟脱氧葡萄糖摄取以诊断心脏设备感染:我们应该何时以及如何进行?
J Nucl Cardiol. 2016 Dec;23(6):1467-1469. doi: 10.1007/s12350-015-0293-2. Epub 2015 Oct 22.
4
Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.细胞因子联合成人自体骨髓祖细胞治疗非缺血性扩张型心肌病患者的随机试验:再生-DCM临床试验
Eur Heart J. 2015 Nov 21;36(44):3061-9. doi: 10.1093/eurheartj/ehv390. Epub 2015 Sep 2.
5
Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction.携带 VEGF 的微载体与脂肪组织间充质细胞的联合移植促进了小鼠心肌梗死的修复。
Cardiovasc Res. 2015 Oct 1;108(1):39-49. doi: 10.1093/cvr/cvv197. Epub 2015 Jul 17.
6
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.在急性心肌梗死猪模型中用人诱导多能干细胞衍生的心血管细胞进行心脏修复。
Cell Stem Cell. 2014 Dec 4;15(6):750-61. doi: 10.1016/j.stem.2014.11.009.
7
Comparison of Magnetic Intensities for Mesenchymal Stem Cell Targeting Therapy on Ischemic Myocardial Repair: High Magnetic Intensity Improves Cell Retention but Has no Additional Functional Benefit.间充质干细胞靶向治疗对缺血性心肌修复的磁场强度比较:高磁场强度可提高细胞滞留率,但无额外功能益处。
Cell Transplant. 2015;24(10):1981-97. doi: 10.3727/096368914X685302. Epub 2014 Nov 5.
8
Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer.缺血性心脏病中联合基因与细胞治疗的相互作用:外泌体微小RNA转移的作用
Circulation. 2014 Sep 9;130(11 Suppl 1):S60-9. doi: 10.1161/CIRCULATIONAHA.113.007917.
9
High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial.高剂量化疗联合自体造血干细胞移植作为既往自体造血干细胞移植后复发多发性骨髓瘤患者的巩固治疗(NCRI 骨髓瘤 X 复发[强化试验]):一项随机、开放标签、3 期试验。
Lancet Oncol. 2014 Jul;15(8):874-85. doi: 10.1016/S1470-2045(14)70245-1. Epub 2014 Jun 16.
10
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.人类胚胎干细胞衍生的心肌细胞可使非人类灵长类动物的心脏再生。
Nature. 2014 Jun 12;510(7504):273-7. doi: 10.1038/nature13233. Epub 2014 Apr 30.